Gerry Gray
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
- Health Informatics top 5%
Papers in
-
- Retinal Diseases and Treatments 2
- Retinal and Optic Conditions 1
- Glaucoma and retinal disorders 1
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Co-authors
- Rachel E. Sherman (1 shared paper)Jeffrey Shuren (1 shared paper)Robert M. Califf (1 shared paper)Robert Temple (1 shared paper)Lilly Q. Yue (2 shared papers)Melissa A. Robb (1 shared paper)Steven A. Anderson (1 shared paper)Lisa M. LaVange (1 shared paper)
- Journals
- Clinical ophthalmology (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)Journal of Biopharmaceutical Statistics (1 paper)Journal of Cardiac Failure (1 paper)
- Partner nations
- United States
In The Last Decade
Gerry Gray
8 papers receiving 1.5k citations
Gerry Gray's Hit Papers
Peers
Comparison fields: 5 of 124
- Statistics and Probability 182
- Health Informatics 25
- Economics and Econometrics 230
- Toxicology 27
- Health Information Management 33
Countries citing papers authored by Gerry Gray
This map shows the geographic impact of Gerry Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerry Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerry Gray more than expected).
Fields of papers citing papers by Gerry Gray
This network shows the impact of papers produced by Gerry Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerry Gray. The network helps show where Gerry Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerry Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Real-World Evidence — What Is It and What Can It Tell Us? Hit paper breakdown → | 2016 | 1359 |
| 2 | 2005 | 92 | |
| 3 | 2016 | 13 | |
| 4 | 2015 | 13 | |
| 5 | 1995 | 12 | |
| 6 | 2022 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2018 | 1 | |
| 9 | 2016 | 1 | |
| 10 | 2025 | 0 |
About Gerry Gray
Gerry Gray is a scholar working on Ophthalmology, Economics and Econometrics, Statistics and Probability, General Health Professions and Toxicology, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (2 papers), Statistical Methods in Clinical Trials (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Retinal Imaging and Analysis (1 paper), Retinal and Optic Conditions (1 paper), Statistical and Computational Modeling (1 paper), Glaucoma and retinal disorders (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Statistics and Probability (182 citations), Health Informatics (25 citations), Economics and Econometrics (230 citations), Toxicology (27 citations) and Health Information Management (33 citations). Gerry Gray has collaborated with scholars based in United States. Frequent co-authors include Rachel E. Sherman, Jeffrey Shuren, Robert M. Califf, Robert Temple, Lilly Q. Yue, Melissa A. Robb, Steven A. Anderson, Lisa M. LaVange, Peter Marks and Gerald J. Dal Pan. Their work appears in journals such as Clinical ophthalmology, Pharmacoepidemiology and Drug Safety, Therapeutic Innovation & Regulatory Science, Journal of Biopharmaceutical Statistics and Journal of Cardiac Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.